ibodutant
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for ibodutant, covering 2010-10-01 to 2017-01-18. Get the full timeline:
Most recent: Clinical Trial Update: 52-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D) [Phase 3]